Egis Pharmaceuticals PLC

Egis Pharmaceuticals is one of the leading generic pharmaceutical companies in Central Eastern Europe, with a history spanning over 110 years. The company operates across the entire pharmaceutical value chain, including research and development, active ingredient (API) manufacturing, and the production of finished dosage forms. A member of the Servier Group, Egis focuses primarily on treating diseases of the cardiovascular and central nervous systems, while also providing solutions in diabetology, dermatology, and wound care. The company has a significant international presence, with products available in over 100 countries and a network of subsidiaries and representative offices in 17 countries.